Senior U.S. Health & Science Correspondent, 3 Times Square
Sharon's Feed
Sep 1, 2014

Nasty, brutish and artsy? Neanderthal hashtag engraving found

NEW YORK (Reuters) – Belying their reputation as the dumb cousins of early modern humans, Neanderthals created cave art, an activity regarded as a major cognitive step in the evolution of humankind, scientists reported on Monday in a paper describing the first discovery of artwork by this extinct species.

The discovery is “a major contribution to the redefinition of our perception of Neanderthal culture,” said prehistorian William Rendu of the French National Centre for Scientific Research, who was not involved in the work. “It is a new and even stronger evidence of the Neanderthal capacity for developing complex symbolic thought” and “abstract expression,” abilities long believed exclusive to early modern humans.

Sep 1, 2014
Sep 1, 2014
Aug 29, 2014
Aug 29, 2014
Aug 29, 2014

Experimental Ebola drug ZMapp cures 100 percent of lab monkeys

NEW YORK, Aug 29 (Reuters) – The experimental Ebola drug
ZMapp cured all 18 of the lab monkeys infected with the deadly
virus, including those suffering the fever and hemorrhaging
characteristic of the disease and just hours from death,
scientists reported on Friday.

Even monkeys not treated until five days after infection
survived. No other experimental Ebola therapy has ever shown
success in primates when given that long after infection; the
five days is analogous to nine to 11 days after infection in
people.

Aug 28, 2014
Aug 28, 2014

GSK Ebola vaccine fast-tracked into U.S., UK and African trials

LONDON/NEW YORK (Reuters) – An experimental Ebola vaccine from GlaxoSmithKline GSK.L is being fast-tracked into human studies and the company plans to build a stockpile of up to 10,000 doses for emergency deployment, if results are good.

The research work is being accelerated with funding from an international consortium, reflecting mounting concern over the worst outbreak of the disease that has killed more than 1,500 people in West Africa.

Aug 28, 2014

Ebola vaccine from GSK fast-tracked into clinical trials

LONDON/NEW YORK (Reuters) – An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into human studies and the company plans to build a stockpile of up to 10,000 doses for emergency deployment, if results are good.

The research work is being accelerated with funding from an international consortium, reflecting mounting concern over the worst outbreak of the disease that has killed more than 1,500 people in West Africa.

Aug 27, 2014

Ebola vaccine from GSK to begin U.S. clinical trials within weeks: sources

NEW YORK (Reuters) – U.S. health officials will announce on Thursday that a human study of an Ebola vaccine made by GlaxoSmithKline will begin within a couple of weeks and not later this year as the company estimated originally, according to people familiar with the plans.

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), will make the announcement as part of a previously scheduled briefing for reporters, the sources said.

    • About Sharon

      "After covering science and medicine at Newsweek, then the Wall Street Journal, then Newsweek again, I joined Reuters in 2012 to report on neuroscience, genetics, cognitive science, and other research. My books have focused on the brain: 2007's Train Your Mind, Change Your Brain (the first popular account of the revolution in neuroplasticity), and 2012's The Emotional Life of Your Brain (with Richard J. Davidson)."
      Joined Reuters:
      2012
      Languages:
      English
    • More from Sharon

      Publications:
      The Emotional Life of Your Brain (2012)
      Train Your Mind, Change Your Brain (2007)
      The Mind and the Brain (2002)
    • Contact Sharon

    • Follow Sharon